SCHEMBL6000915

SCHEMBL6000915

CN(Cc1ccc(C2CCCCC2)cc1)c1ccc(-c2csc(CN3CCC(C(=O)O)(c4ccccc4)CC3)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 2/20 0.38
CTSB P07858 2/20 0.38
CTSS P25774 2/20 0.38
LTA4H P09960 1/20 0.38
TRPA1 O75762 1/20 0.35
CYP3A4 P08684 1/20 0.35
HTT P42858 1/20 0.35
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
ENPP2 Q13822 1/20 0.35
STAT3 P40763 2/20 0.35
STAT1 P42224 1/20 0.35
STAT5B P51692 1/20 0.35
TACR3 P29371 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
MRE11 P49959 1/20 0.34
DHODH Q02127 1/20 0.34
MAPK1 P28482 1/20 0.34
ELOVL1 Q9BW60 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6000685 0.93 LTA4H (0.37) CTSLCTSBCTSSLTA4HHTT
SCHEMBL6000690 0.93 LTA4H (0.37) CTSLCTSBCTSSLTA4HHTT
SCHEMBL6000564 0.86 S1PR1 (0.42) CTSLCTSBCTSSLTA4HTRPA1
SCHEMBL6000648 0.86 ITGB3 (0.42) CTSLCTSBCTSSTRPA1HTT
SCHEMBL6001092 0.85 CTSL (0.38) CTSLCTSBCTSSTRPA1HTT
SCHEMBL6000114 0.84 NPC1 (0.37) LTA4HENPP2RAB9A
SCHEMBL6000118 0.84 NPC1 (0.37) LTA4HENPP2RAB9A
SCHEMBL6000920 0.84 MEN1 (0.39) CTSLCTSBCTSSLTA4HTRPA1
SCHEMBL5999096 0.82 S1PR1 (0.44) LTA4HHTTMEN1KMT2AMAPK1
SCHEMBL6000602 0.81 STAT3 (0.41) TRPA1STAT3STAT1STAT5BMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 CTSL 4264/4885CTSB 1634/4885CTSS 2354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.